TRHC - タブラ・ラサ・ヘルスケア (Tabula Rasa HealthCare Inc.)

TRHCのニュース

   Tabula Rasa HealthCare Reports First Quarter 2021 Results  2021/05/06 20:30:00 Benzinga
MOORESTOWN, N.J. , May 6, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC ), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the first quarter ended March 31, 2021 . "I am pleased with the solid start to 2021 with first quarter revenue at the high end of our guidance range. We had an eventful quarter with a number of notable developments to start the year including: 1) a faster-than-expected return to historical PACE enrollment growth rates in March, which has continued into the second quarter of 2021; 2) a flurry of governmental policy activity at the federal level such as the PACE Plus Act that could exponentially expand the size of the PACE market; and 3) a publication in a peer-reviewed journal of an important study, with several more in the pipeline, which further validates and reinforces the strong outcomes and ROI associated with our MedWise® science," said Calvin H. Knowlton , PhD, TRHC's Chief Executive Officer, Chairman and Founder.
   Tabula Rasa HealthCare Partners with athenahealth's Marketplace Program to Provide Medication Decision Support Tools  2021/04/08 12:00:00 Yahoo Finance
Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC), a healthcare technology company advancing safe use of medications, today announced a partnership with athenahealth, Inc. to provide TRHC's MedWise® technology through the athenahealth Marketplace program. MedWise medication decision support tools identify simultaneous, accumulative, multi-drug interactions, enabling providers to improve medication safety, efficacy, and adherence. As part of the athenahealth Marketplace, this newly integrated application is now available to athenahealth's growing network of healthcare providers, in particular those in need of quality improvement and total cost reduction.
   Tabula Rasa’s 4Q Sales Beat Estimates; Street Sees 18% Upside  2021/02/24 13:45:34 Smarter Analyst
Tabula Rasa HealthCare delivered better-than-expected sales in the fourth quarter as the patient medication safety solutions provider saw an increase in demand for … The post Tabula Rasa’s 4Q Sales Beat Estimates; Street Sees 18% Upside appeared first on Smarter Analyst .
   PrimeRx™ and Tabula Rasa HealthCare Now Offer Integration Technology for Automated COVID-19 Vaccine Reporting  2021/02/16 13:15:00 PR Newswire
SYOSSET, N.Y., Feb. 16, 2021 /PRNewswire/ -- Micro Merchant Systems announces that its PrimeRx™ pharmacy technology software offers direct integration with the automated immunization reporting solution offered by Tabula Rasa HealthCare's (TRHC) Script Management Partners (SMP). With this…
   Tabula Rasa HealthCare Fourth Quarter and Full Year 2020 Earnings Conference Call Announcement  2021/02/11 13:00:00 Yahoo Finance
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its fourth quarter and full year 2020 operating results on Wednesday, February 24, 2021 at 8:30 a.m. EDT. The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, PhD; TRHC Co-Founder and President, Orsula V. Knowlton, PharmD; and TRHC Chief Financial Officer, Brian W. Adams. The Company's financial results for the fourth quarter and full year ending December 31, 2020, will be released after the close of the market on Tuesday, February 23, 2021.
   Tabula Rasa HealthCare Reports First Quarter 2021 Results  2021/05/06 20:30:00 Benzinga
MOORESTOWN, N.J. , May 6, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC ), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the first quarter ended March 31, 2021 . "I am pleased with the solid start to 2021 with first quarter revenue at the high end of our guidance range. We had an eventful quarter with a number of notable developments to start the year including: 1) a faster-than-expected return to historical PACE enrollment growth rates in March, which has continued into the second quarter of 2021; 2) a flurry of governmental policy activity at the federal level such as the PACE Plus Act that could exponentially expand the size of the PACE market; and 3) a publication in a peer-reviewed journal of an important study, with several more in the pipeline, which further validates and reinforces the strong outcomes and ROI associated with our MedWise® science," said Calvin H. Knowlton , PhD, TRHC's Chief Executive Officer, Chairman and Founder.
   Tabula Rasa HealthCare Partners with athenahealth's Marketplace Program to Provide Medication Decision Support Tools  2021/04/08 12:00:00 Yahoo Finance
Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC), a healthcare technology company advancing safe use of medications, today announced a partnership with athenahealth, Inc. to provide TRHC's MedWise® technology through the athenahealth Marketplace program. MedWise medication decision support tools identify simultaneous, accumulative, multi-drug interactions, enabling providers to improve medication safety, efficacy, and adherence. As part of the athenahealth Marketplace, this newly integrated application is now available to athenahealth's growing network of healthcare providers, in particular those in need of quality improvement and total cost reduction.
   Tabula Rasa’s 4Q Sales Beat Estimates; Street Sees 18% Upside  2021/02/24 13:45:34 Smarter Analyst
Tabula Rasa HealthCare delivered better-than-expected sales in the fourth quarter as the patient medication safety solutions provider saw an increase in demand for … The post Tabula Rasa’s 4Q Sales Beat Estimates; Street Sees 18% Upside appeared first on Smarter Analyst .
   PrimeRx™ and Tabula Rasa HealthCare Now Offer Integration Technology for Automated COVID-19 Vaccine Reporting  2021/02/16 13:15:00 PR Newswire
SYOSSET, N.Y., Feb. 16, 2021 /PRNewswire/ -- Micro Merchant Systems announces that its PrimeRx™ pharmacy technology software offers direct integration with the automated immunization reporting solution offered by Tabula Rasa HealthCare's (TRHC) Script Management Partners (SMP). With this…
   Tabula Rasa HealthCare Fourth Quarter and Full Year 2020 Earnings Conference Call Announcement  2021/02/11 13:00:00 Yahoo Finance
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its fourth quarter and full year 2020 operating results on Wednesday, February 24, 2021 at 8:30 a.m. EDT. The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, PhD; TRHC Co-Founder and President, Orsula V. Knowlton, PharmD; and TRHC Chief Financial Officer, Brian W. Adams. The Company's financial results for the fourth quarter and full year ending December 31, 2020, will be released after the close of the market on Tuesday, February 23, 2021.
   Tabula Rasa HealthCare Reports First Quarter 2021 Results  2021/05/06 20:30:00 Benzinga
MOORESTOWN, N.J. , May 6, 2021 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC ), a leading healthcare technology company advancing the safe use of medications, today reported financial results for the first quarter ended March 31, 2021 . "I am pleased with the solid start to 2021 with first quarter revenue at the high end of our guidance range. We had an eventful quarter with a number of notable developments to start the year including: 1) a faster-than-expected return to historical PACE enrollment growth rates in March, which has continued into the second quarter of 2021; 2) a flurry of governmental policy activity at the federal level such as the PACE Plus Act that could exponentially expand the size of the PACE market; and 3) a publication in a peer-reviewed journal of an important study, with several more in the pipeline, which further validates and reinforces the strong outcomes and ROI associated with our MedWise® science," said Calvin H. Knowlton , PhD, TRHC's Chief Executive Officer, Chairman and Founder.
   Tabula Rasa HealthCare Partners with athenahealth's Marketplace Program to Provide Medication Decision Support Tools  2021/04/08 12:00:00 Yahoo Finance
Tabula Rasa HealthCare, Inc. ("TRHC") (NASDAQ: TRHC), a healthcare technology company advancing safe use of medications, today announced a partnership with athenahealth, Inc. to provide TRHC's MedWise® technology through the athenahealth Marketplace program. MedWise medication decision support tools identify simultaneous, accumulative, multi-drug interactions, enabling providers to improve medication safety, efficacy, and adherence. As part of the athenahealth Marketplace, this newly integrated application is now available to athenahealth's growing network of healthcare providers, in particular those in need of quality improvement and total cost reduction.
   Tabula Rasa’s 4Q Sales Beat Estimates; Street Sees 18% Upside  2021/02/24 13:45:34 Smarter Analyst
Tabula Rasa HealthCare delivered better-than-expected sales in the fourth quarter as the patient medication safety solutions provider saw an increase in demand for … The post Tabula Rasa’s 4Q Sales Beat Estimates; Street Sees 18% Upside appeared first on Smarter Analyst .
   PrimeRx™ and Tabula Rasa HealthCare Now Offer Integration Technology for Automated COVID-19 Vaccine Reporting  2021/02/16 13:15:00 PR Newswire
SYOSSET, N.Y., Feb. 16, 2021 /PRNewswire/ -- Micro Merchant Systems announces that its PrimeRx™ pharmacy technology software offers direct integration with the automated immunization reporting solution offered by Tabula Rasa HealthCare's (TRHC) Script Management Partners (SMP). With this…
   Tabula Rasa HealthCare Fourth Quarter and Full Year 2020 Earnings Conference Call Announcement  2021/02/11 13:00:00 Yahoo Finance
Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its fourth quarter and full year 2020 operating results on Wednesday, February 24, 2021 at 8:30 a.m. EDT. The conference call will be hosted by TRHC CEO, Chairman and Founder, Calvin H. Knowlton, PhD; TRHC Co-Founder and President, Orsula V. Knowlton, PharmD; and TRHC Chief Financial Officer, Brian W. Adams. The Company's financial results for the fourth quarter and full year ending December 31, 2020, will be released after the close of the market on Tuesday, February 23, 2021.

calendar